WEST-KOaST Study: WES Analysis of Testicular Cancer Patientsand Their First-degree Family Members

Launched by IRCCS SAN RAFFAELE · Nov 16, 2023

Keywords

ClinConnect Summary

The WEST-KOaST Study is a clinical trial that is looking at testicular cancer to better understand what might cause this disease and how certain genes could play a role. The goal is to find out if there are specific genetic factors that increase the risk of testicular cancer in patients and their close family members. This research is important as it could lead to better prevention and treatment options in the future.

To participate in this study, you need to be a male testicular cancer patient aged between 18 and 90, or a first-degree family member (like a father, brother, or son) of a testicular cancer patient, also aged between 18 and 90. Participants will be asked to read and sign a consent form to ensure they understand the study. While the trial is not yet recruiting participants, it is essential to know that it will involve evaluating genetic information, and all participants can expect to contribute valuable insights that could help others facing testicular cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male testicular cancer patients with an age \> 18 and \< 90
• • First degree family members of Male testicular cancer patients with an age \> 18 and \< 90
• • Ability to read and sign the informed consent
• • Diagnosis of testicular cancer for the experimental group
• Exclusion Criteria:
• • Female for the experimental group
• • Second degree family members of Male testicular cancer patients
• • People with an age \< 18 and \> 90
• • Diagnosis different from testicular cancer for the experimental group Incapacity to read and sign the informed consent